| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Revenue | $2.7M | — | +827.7% |
| Cost of Revenue | $103K | — | +1371.4% |
| R&D Expense | $141K | — | -16.6% |
| SG&A Expense | $6.0M | — | +1004.2% |
| Operating Income | -$55.2M | — | -6152.5% |
| Interest Expense | $2.2M | — | — |
| Pre-tax Income | -$83.4M | — | — |
| Income Tax | $0 | — | — |
| Net Income | -$83.4M | — | — |
| EPS (Basic) | -$3.18 | — | -478.2% |
| EPS (Diluted) | -$3.18 | — | -478.2% |
| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Short-term Investments | $2.7M | -26.7% | +533.0% |
| Current Assets | $127.8M | +4.8% | +4082.5% |
| Total Assets | $229.7M | -25.3% | +5424.6% |
| Current Liabilities | $91.7M | +13.6% | +8581.5% |
| Long-term Debt | $127.8M | +0.3% | — |
| Total Liabilities | $219.5M |
| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Operating Cash Flow | -$9.8M | — | -1149.6% |
| Investing Cash Flow | $16.2M | — | — |
| Financing Cash Flow | -$8.6M | — | — |
| — |
| Stockholders' Equity | $10.2M | -89.7% | +258.0% |